Pharmacokinetic Study of Aralast (Human Alpha1- PI) - Contacts and Locations

Pharmacokinetic Study of Aralast (Human Alpha1- PI)

This study has been completed.

Study NCT00242385. Last updated on October 31, 2006. Information provided by Baxter Healthcare Corporation

Please refer to this study by its ClinicalTrials.gov identifier: NCT00242385

Locations


Australia, South Australia
	The Queen Elizabeth Hospital
	Woodville, South Australia, Australia
	Royal Adelaide Hospital
	Adelaide, South Australia, Australia

Australia, Victoria
	St. Vincent´s Hospital
	Fitzroy, Victoria, Australia

Australia, Western Australia
	Sir Charles Gairdner Hospital
	Nedlands, Western Australia, Australia

New Zealand
	Christchurch Hospital, Canterbury Respiratory Research Group
	Christchurch, New Zealand
	Waikato Hospital, Respiratory Department
	Hamilton, New Zealand

New Zealand, Auckland
	Middlemore Hospital
	Otahuhu, Auckland, New Zealand

Sponsors and Collaborators

Baxter Healthcare Corporation

Investigators


Principal Investigator:	Jeff Garrett, MD	Middlemore Hospital, Otahuhu, Auckland, New Zealand